Commentary published on the FDA panel discussion about SSRI use in pregnancy

Professor Per Damkier (the outgoing Chair of the ENTIS Scientific Committee) and Dr Matitiahu Berkovitch (President of ENTIS) have published a commentary in the British Journal of Obstetrics and Gynaecology discussing the FDA panel discussion (broadcast 21 July 2025) about the safety of selective serotonin reuptake inhibitors (SSRI) in pregnancy. Photo by Sam Szuchan on Unsplash

» Read more

Umbrella review of systematic reviews investigating claims of increased ASD and ADHD risks following maternal paracetamol use published

Researchers from Liverpool University have published an umbrella review of systematic reviews investigating maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder. The authors concluded that confidence in the current evidence was considered low to critically low. More information is available here. Photo by James Yarema on Unsplash

» Read more

Commentary published discussing a recent study of acetaminophen exposure and childhood attention deficit hyperactivity disorder

ENTIS members Prof Per Damkier and Dr Erika Gram have published a commentary discussing the methodological advantages and limitations of a new study of Commentary published discussing a recent study of acetaminophen exposure and childhood attention deficit hyperactivity disorder (Baker et al. 2025 – see here). Photo by Tara Winstead downloaded from Pexels

» Read more
1 2 3 4 5 34